Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy.
about
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wastingSatellite cells in human skeletal muscle plasticityThe methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophyMechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans.Single muscle fiber gene expression with run taper.Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilizationInfluence of exercise on the metabolic profile caused by 28 days of bed rest with energy deficit and amino acid supplementation in healthy menMyostatin levels in skeletal muscle of hibernating ground squirrelsTranslational signalling, atrogenic and myogenic gene expression during unloading and reloading of skeletal muscle in myostatin-deficient mice.Role of TGF-β signaling in inherited and acquired myopathies.Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression.Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.Targeting the myostatin signaling pathway to treat muscle wasting diseasesEndoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis.Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditureMyostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney DiseaseThe therapeutic potential of agents that inactivate myostatin.The role of myostatin and bone morphogenetic proteins in muscular disorders.The possible role of myostatin in skeletal muscle atrophy and cachexia.Developmental Biology and Regenerative Medicine: Addressing the Vexing Problem of Persistent Muscle Atrophy in the Chronically Torn Human Rotator CuffImpaired regeneration: A role for the muscle microenvironment in cancer cachexia.Myostatin in the pathophysiology of skeletal muscle.Coordinated patterns of gene expressions for adult muscle build-up in transgenic mice expressing myostatin propeptide.Procysteine stimulates expression of key anabolic factors and reduces plantaris atrophy in alcohol-fed rats.Skeletal muscle wasting with disuse atrophy is multi-dimensional: the response and interaction of myonuclei, satellite cells and signaling pathways.Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin.Myostatin--the holy grail for muscle, bone, and fat?Exercise-induced signal transduction and gene regulation in skeletal muscle.The role of mechanobiology in progression of rotator cuff muscle atrophy and degeneration.Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities.Hypothyroidism is associated with increased myostatin expression in rats.Transcriptional pathways associated with skeletal muscle disuse atrophy in humans.Protein and Amino Acid Supplementation Does Not Alter Proteolytic Gene Expression following Immobilization.Immunological and growth mediator response to cross-country training in adolescent females.The myostatin-induced E3 ubiquitin ligase RNF13 negatively regulates the proliferation of chicken myoblasts.Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining.Leucine minimizes denervation-induced skeletal muscle atrophy of rats through akt/mtor signaling pathways.Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin.The effect of endurance-type exercise training on growth mediators and inflammatory cytokines in pre-pubertal and early pubertal males.The effect of a low dose of clenbuterol on rat soleus muscle submitted to joint immobilization.
P2860
Q24609841-9A3A568B-2D79-432B-89B0-E8AC41009BBCQ26777962-BAA8DC82-DAE2-4DC4-833B-ED2C9877A754Q28592692-5262A8AA-AAF7-4C51-8517-C5D4913A6DC4Q34146722-ACB10BF1-E001-48E4-A6A1-BA8331A90975Q34277356-0373BE80-82B0-43D4-9CCA-A021F4E0FA99Q34305212-97808A72-A995-4B61-9B13-58117EBF2FB2Q34334204-3BB11BFD-6D64-4DC0-81EC-91D2813503A8Q35102406-D0315A9C-068F-46E5-BC46-77D71ABD1878Q35144174-F0F33E13-AD7D-410C-8AC9-E49DB8395A7DQ35166254-A4A71FC2-DBA0-4767-BC75-21744308F3FDQ35174188-204109A1-9D27-4518-963D-60838663ED1DQ35207442-746341DD-5EF0-43AD-AE8D-4E8A7F74E0D5Q35739702-A36523D4-2413-4BB8-9335-8979794852CCQ35873911-89361654-6935-4A3C-B03E-499D8151ED35Q36003155-72F31DF1-C6CD-4C67-878A-241E8072B96AQ36095662-9CF228DB-DC96-4A10-A267-9CA11ED75560Q36249879-D76D5164-E94C-42A2-B6BD-E1FE6CD0F1E9Q36377213-3EB232E7-2146-4C71-A838-39354BB99E37Q36419733-50B1CEA4-A843-4D02-932B-D8AB6BD86075Q36875163-281E8210-1957-4467-A942-15B3B097495CQ37042189-DC69114E-5F50-4A7E-A875-1CBB12E676CFQ37108137-E026424F-E0CF-47D8-A3C1-0F89AA37DBF6Q37270488-F5916F8E-D96A-47A3-956C-2ED1064A18E9Q37295538-BD49B95A-6AB7-4CC0-9D5F-51D794F838DBQ37640550-F0BC9D5C-5C70-442A-8FA6-2BA25B606929Q38071921-8E9232CA-0D44-446A-B6FE-6F1F55DB8F0DQ38144994-F27BED62-78AA-4E91-A51D-EDD3A3CEC55DQ38205760-A5CDA5A4-34F1-4E55-AE7E-71303506B6A3Q38654037-8C7B50EA-097C-4619-93FC-867B643DB636Q38811545-4DEB304A-9D21-4FE7-8483-342D1D22E4F8Q39919378-EB69FFF5-332B-4968-A380-B3427F2E8D1BQ40177102-9D040688-3F3F-4499-8D34-2656CA5984B3Q41898403-BF26D460-4F3C-4AAB-92F0-2AD0413CE61DQ43184130-EE8CCC8C-096B-4B8E-BE26-CF98E6D1A29DQ43674628-2E92B343-9C75-4CE5-B78F-9819A0D93200Q43850408-EE48D976-24B1-4414-BB86-AB0820D07A0BQ44365092-66D7B576-8297-4CA5-B637-47B8D358B92AQ44489665-AF0E4D19-26B3-46D0-B348-64D3DBD0F9E6Q44518132-20F6A1E3-090D-4952-B092-5B762A49654AQ46160488-8EEF6EAA-E959-4861-B251-8480644A51E1
P2860
Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Myostatin, insulin-like growth ...... c human disuse muscle atrophy.
@ast
Myostatin, insulin-like growth ...... c human disuse muscle atrophy.
@en
type
label
Myostatin, insulin-like growth ...... c human disuse muscle atrophy.
@ast
Myostatin, insulin-like growth ...... c human disuse muscle atrophy.
@en
prefLabel
Myostatin, insulin-like growth ...... c human disuse muscle atrophy.
@ast
Myostatin, insulin-like growth ...... c human disuse muscle atrophy.
@en
P2093
P356
P1433
P1476
Myostatin, insulin-like growth ...... ic human disuse muscle atrophy
@en
P2093
P304
P356
10.1002/MUS.1086
P577
2001-07-01T00:00:00Z